Understanding Meniere's Disease

Meniere's disease is a disorder of the inner ear that causes episodes of vertigo, fluctuating hearing loss, tinnitus, and a feeling of fullness or pressure in the affected ear. The condition is thought to result from an abnormal buildup of endolymphatic fluid within the labyrinth of the inner ear. For individuals who do not respond to conservative management such as dietary changes, diuretics, or oral vestibular suppressants, a more targeted approach may be necessary to control debilitating vertigo attacks.

What Is Intratympanic Gentamicin Therapy?

Intratympanic gentamicin is a treatment in which the antibiotic gentamicin is injected directly into the middle ear space through the eardrum. Because the drug diffuses across the round window membrane into the inner ear, this approach delivers a high concentration of medication precisely to the vestibular system while minimizing systemic side effects. The term transtympanic is used interchangeably with intratympanic, referring to the passage of the needle through the tympanic membrane. This form of treatment is considered when vertigo attacks remain frequent and disabling despite medical therapy.

How the Transtympanic Injection Works

During an intratympanic gentamicin procedure, the ear is first inspected and cleaned. A local anesthetic may be applied to the eardrum to reduce discomfort. Using a small needle, the clinician passes through the tympanic membrane and deposits a small volume of gentamicin solution into the middle ear. The patient is typically asked to lie still with the head turned so that the medication can bathe the round window membrane, which is the gateway to the inner ear. Over time, the gentamicin is absorbed into the perilymph, where it exerts a toxic effect on the vestibular hair cells, particularly those of the semicircular canals. This chemical ablation reduces abnormal balance signals that cause vertigo.

Why Gentamicin Is Used

Gentamicin is an aminoglycoside antibiotic with known vestibulotoxic properties. While this effect is normally an unwanted side effect, in Meniere's disease it is harnessed therapeutically. By selectively damaging vestibular hair cells, intratympanic gentamicin reduces the intensity and frequency of vertigo spells. The goal is to achieve control of vertigo while preserving as much hearing as possible, although some degree of hearing loss can occur. The dose and number of injections are tailored to each patient, with some receiving a single injection and others requiring a short series of treatments.

The Procedure and What to Expect

Intratympanic gentamicin is usually performed in an outpatient clinic setting. The procedure itself is brief, often lasting only a few minutes. Patients may feel a mild sting or pressure when the needle passes through the eardrum. After the injection, the patient remains lying down for a short period to allow the medication to be absorbed. Common temporary effects include dizziness, a sense of imbalance, or a temporary worsening of tinnitus. These sensations typically settle as the vestibular system adjusts. Most individuals can resume normal activities within a day or two, though balance may take longer to stabilize.

Effectiveness of Intratympanic Gentamicin

Clinical experience has shown that intratympanic gentamicin is highly effective in reducing vertigo attacks in Meniere's disease. Many patients experience a significant reduction in the number and severity of episodes, and some become free of vertigo altogether. The treatment is particularly useful for individuals with unilateral disease who have not benefited from oral medications. Hearing preservation remains a primary concern, and for this reason many clinicians adopt a low-dose or titrated protocol. Regular audiometric monitoring is used to detect any changes in hearing early, allowing the treatment to be adjusted or stopped if necessary.

Potential Risks and Side Effects

The most important risk of transtympanic gentamicin therapy is hearing loss, which can be permanent in some cases. Although the damage is intended to affect the vestibular system, gentamicin can also injure cochlear hair cells, especially with higher doses or repeated injections. Other potential risks include persistent dizziness, a feeling of unsteadiness, eardrum perforation, infection, or worsening of tinnitus. The treating clinician will carefully weigh these risks against the disability caused by uncontrolled vertigo. Patients are advised to report any new hearing loss, discharge, or severe dizziness promptly.

Aftercare and Follow-Up

Following intratympanic gentamicin treatment, patients may be advised to avoid getting water in the ear for a short period and to refrain from vigorous nose blowing to allow the eardrum to heal. Follow-up appointments are scheduled to evaluate hearing and balance function. Additional injections may be recommended if vertigo returns, but clinicians generally avoid unnecessary repeat treatments to protect hearing. Vestibular rehabilitation exercises are sometimes suggested to help the brain compensate for the altered balance signals after chemical ablation.

Summary

Intratympanic gentamicin offers a targeted and effective option for controlling vertigo in Meniere's disease when conventional treatments fail. With careful patient selection, appropriate dosing, and regular audiometric monitoring, this transtympanic treatment can dramatically improve quality of life by reducing the burden of unpredictable vertigo attacks. As with any medical procedure, the decision to proceed should be made in partnership with an experienced ear specialist who can discuss the expected benefits and potential risks in detail.